Terms: = Breast cancer AND RHOA, ENSG00000067560, 387, ARHA, RhoA, RHOH12, RHO12, ARH12, Rho12 AND Treatment
192 results:
1. Real-World Analysis of the Clinical and Economic Impact of the 21-Gene Recurrence Score (RS) in Invasive Lobular Early-Stage breast Carcinoma in Ireland.
McSorley LM; Tharmabala M; Al Rahbi F; Keane F; Evoy D; Geraghty JG; Rothwell J; McCartan DP; Greally M; O'Connor M; O'Mahony D; Keane M; Kennedy MJ; O'Reilly S; Millen SJ; Crown JP; Kelly CM; Prichard RS; Quinn CM; Walshe JM
Curr Oncol; 2024 Mar; 31(3):1302-1310. PubMed ID: 38534931
[No Abstract] [Full Text] [Related]
2. Assessment of the Surgical Oncology Case Volume Within the Public Sector in Tanzania.
Brand NR; Akoko L; Kotecha V; Mwakyembe T; Mwashambwa M; Hamid R; Hando D; Komba C; Mwanga A; Mbele P; Itule P; Jackson J; Misidai M; Gaskill C; Ozgediz D
JCO Glob Oncol; 2024 Mar; 10():e2300316. PubMed ID: 38452305
[TBL] [Abstract] [Full Text] [Related]
3. Cost-effectiveness analysis of add-on pertuzumab to trastuzumab biosimilar and chemotherapy as neoadjuvant treatment for human epidermal growth receptor 2-positive early breast cancer patients in Singapore.
Lim EH; Lim A; Khara JS; Cheong J; Fong J; Sivanesan S; Griffiths M; New E; Lee SC
Expert Rev Pharmacoecon Outcomes Res; 2024 Mar; 24(3):413-426. PubMed ID: 38289042
[TBL] [Abstract] [Full Text] [Related]
4. ARHGAP6 Suppresses breast cancer Tumor Growth by Promoting Ferroptosis via rhoa-ROCK1-p38 MAPK Signaling.
Chen X; Zhu J; Li X; Chen J; Zhou Z; Fan X; Liang R; Liu H; Zhu D
Front Biosci (Landmark Ed); 2024 Jan; 29(1):6. PubMed ID: 38287795
[TBL] [Abstract] [Full Text] [Related]
5. Analysis of breast cancer Screening Results and Influencing Factors of breast cancer in Guangdong Province from 2017 to 2021.
Wu L; Chen GZ; Zeng ZR; Ji CW; Zhang AQ; Xia JH; Liu GC
J Epidemiol Glob Health; 2024 Mar; 14(1):131-141. PubMed ID: 38224387
[TBL] [Abstract] [Full Text] [Related]
6. The Anticancer Effects of Marine Carotenoid Fucoxanthin through Phosphatidylinositol 3-Kinase (PI3K)-AKT Signaling on Triple-Negative breast cancer Cells.
Ahmed SA; Mendonca P; Messeha SS; Oriaku ET; Soliman KFA
Molecules; 2023 Dec; 29(1):. PubMed ID: 38202644
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic impact of cancer genomic profile testing for advanced or metastatic solid tumors in clinical practice.
Fukada I; Mori S; Hayashi N; Hosonaga M; Xiaofei W; Yamazaki M; Ueki A; Kiyotani K; Tonooka A; Takeuchi K; Ueno T; Takahashi S
Cancer Sci; 2023 Dec; 114(12):4632-4642. PubMed ID: 37858313
[TBL] [Abstract] [Full Text] [Related]
8. Quality indicators for the diagnosis and treatment of breast cancer integrated assistance: A critical appraisal.
Maes-Carballo M; Martín-Díaz M; Mignini L; Khan KS; Trigueros R; Bueno-Cavanillas A
Semergen; 2024; 50(1):102067. PubMed ID: 37827047
[TBL] [Abstract] [Full Text] [Related]
9. Factors Predicting Response in breast cancer Receiving Neoadjuvant Therapy and the Role of Ki67 Labeling Index.
Ekinci F; Uzun M; Demir B; Unek IT; Erdogan AP
J Coll Physicians Surg Pak; 2023 Aug; 33(8):872-878. PubMed ID: 37553925
[TBL] [Abstract] [Full Text] [Related]
10. The Role of
Géci I; Bober P; Filová E; Amler E; Sabo J
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511111
[TBL] [Abstract] [Full Text] [Related]
11. Analysis of the adequacy of control arms in oncology randomised clinical trials published between 2017 and 2021: a meta-research study.
Rossi A; Aimar G; Audisio M; Bungaro M; Caglio A; Di Liello R; Gamba T; Gargiulo P; Ghisoni E; Lombardi P; Marandino L; Mariniello A; Paratore C; Reale ML; Trastu F; Tuninetti V; Turco F; Fabi A; Perrone F; Di Maio M
Eur J Cancer; 2023 Aug; 189():112920. PubMed ID: 37277262
[TBL] [Abstract] [Full Text] [Related]
12. Solasodine suppresses the metastasis of gastric cancer through claudin-2 via the AMPK/STAT3/NF-κB pathway.
Su K; Yao X; Guo C; Qian C; Wang Y; Ma X; Wang X; Yang Y
Chem Biol Interact; 2023 Jul; 379():110520. PubMed ID: 37121296
[TBL] [Abstract] [Full Text] [Related]
13. PD-1 Independent Role of PD-L1 in Triple-Negative breast cancer Progression.
Alkaabi D; Arafat K; Sulaiman S; Al-Azawi AM; Attoub S
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047395
[TBL] [Abstract] [Full Text] [Related]
14. Polyisoprenylated cysteinyl amide inhibitors deplete singly polyisoprenylated monomeric G-proteins in lung and breast cancer cell lines.
Tawfeeq N; Lazarte JMS; Jin Y; Gregory MD; Lamango NS
Oncotarget; 2023 Mar; 14():243-257. PubMed ID: 36961909
[TBL] [Abstract] [Full Text] [Related]
15. Two fragments of HBV DNA integrated into chrX: 11009033 and its genetic regulation in HepG2.2.15.
Ruan P; Zhou R; He C; Huang C; Lin M; Yin H; Dai X; Sun J
Mol Med Rep; 2023 May; 27(5):. PubMed ID: 36960866
[TBL] [Abstract] [Full Text] [Related]
16. Automated breast ultrasound (ABUS) for intraoperative margin control on surgical specimens in breast conserving surgery.
Hatzipanagiotou ME; Huber D; Thede E; Scheiter A; Fernandez-Pacheco M; Hetterich M; Roca Ripoll B; Ortmann O; Seitz S
Arch Gynecol Obstet; 2023 Jun; 307(6):1949-1955. PubMed ID: 36503976
[TBL] [Abstract] [Full Text] [Related]
17. Radioactive iodine in low- to intermediate-risk papillary thyroid cancer.
Zhao H; Gong Y
Front Endocrinol (Lausanne); 2022; 13():960682. PubMed ID: 36034423
[TBL] [Abstract] [Full Text] [Related]
18. Cost Effectiveness of Ribociclib and Palbociclib in the Second-Line treatment of Hormone Receptor-Positive, HER2-Negative Metastatic breast cancer in Post-Menopausal Indian Women.
Gupta N; Gupta D; Dixit J; Mehra N; Singh A; Krishnamurthy MN; Jyani G; Rajsekhar K; Kalaiyarasi JP; Roy PS; Malik PS; Mathew A; Malhotra P; Gupta S; Kumar L; Kataki A; Prinja S
Appl Health Econ Health Policy; 2022 Jul; 20(4):609-621. PubMed ID: 35534752
[TBL] [Abstract] [Full Text] [Related]
19. Hesperetin Inhibits TGF-β1-Induced Migration and Invasion of Triple Negative breast cancer MDA-MB-231 Cells via Suppressing Fyn/Paxillin/rhoa Pathway.
Lu Q; Lai Y; Zhang H; Ren K; Liu W; An Y; Yao J; Fan H
Integr Cancer Ther; 2022; 21():15347354221086900. PubMed ID: 35297710
[TBL] [Abstract] [Full Text] [Related]
20. Feasibility study on collecting patient-reported outcomes from breast cancer patients using the LINE-ePRO system.
Hayashida T; Nagayama A; Seki T; Takahashi M; Matsumoto A; Kubota A; Jinno H; Miyata H; Kitagawa Y
Cancer Sci; 2022 May; 113(5):1722-1730. PubMed ID: 35279907
[TBL] [Abstract] [Full Text] [Related]
[Next]
